Evaluation of subunit vaccines against feline immunodeficiency virus infection

Vaccine

Volumn 14, Issue 4, 1996, Pages 285-289

  Verschoor, Ernst J ^a   Willemse, Marja J ^b   Stam, Jeanette G ^d   Van Vliet, Arno L W ^a   Pouwels, Henk ^b   Chalmers, Stuart K ^b   Horzinek, Marian C ^a   Sondermeijer, Paul J A ^b   Hesselink, Wim ^b   De Ronde, Anthony ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b INTERVET INTERNATIONAL BV   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

feline herpesvirus vector; feline immunodeficiency virus; FIV; subunit vaccine; vaccination

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; QUIL A; VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; MUTANT; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

EID: 18244425954     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00205-F     Document Type: Article

References (38)

1. Gallo, R.C., Salahuddin, S.Z., Popovic, M. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224, 500-503
2. Barré-Sinoussi, F., Chermann, J.C., Rey, F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220, 868-871
3. Jarrett, O., Yamamoto, J.K. and Neil, J.C. Feline immunodeficiency virus as a model for AIDS vaccination. AIDS 1990, 4 Suppl. 1, S163-S165
4. Egberink, H. and Horzinek, M.C. Animal immunodeficiency viruses. Vet. Microbiol. 1992, 33, 311-331
5. Bendinelli, M., Pistello, M., Matteucci, D. et al. Small animal model of AIDS and the feline immunodeficiency virus. Adv. Exp. Med. Biol. 1993, 335, 189-202
6. Berman, P.W., Gregory, T.J., Riddle, L. et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 1990, 345, 622-625
7. Girard, M., Kieny, M.-P., Pinter, A. et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl Acad. Sci. USA 1991, 88, 542-546
8. Hu, S.-L., Abrams, K., Barber, G.N. et al. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 1992, 255, 456-459
9. Issel, C.J., Horohov, D.W., Lea, D.F. et al. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 1992, 66, 3398-3408
10. Fultz, P.N., Nara, P., Barré-Sinoussi, F. et al. Vaccine protection of chimpanzees against challenge with HIV-1 infected peripheral blood mononuclear cells. Science 1992, 256, 1687-1690
11. Heeney, J.L., De Vries, P., Dubbes, R. et al. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. J. Med. Primatol. 1992, 21, 126-130
12. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. and Desrosiers, R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258, 1938-1941
13. Heeney, J.L., Holterman, L., ten Haaft, P. et al. Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res. Hum. Retrovir. 1994, 10 Suppl. 2, S117-S121
14. Yamamoto, J.K., Okuda, T., Ackley, C.D. et al. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retrovir. 1991, 7, 911-922
15. Yamamoto, J.K., Hohdatsu, T., Olmsted, R.A. et al. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 1993, 67, 601-605
16. Hohdatsu, T., Pu, R., Torres, B.A., Trujillo, S., Gardner, M.B. and Yamamoto, J.K. Passive antibody protection of cats against feline immunodeficiency virus infection. J. Virol. 1993, 67, 2344-2348
17. Lombardi, S., Garzelli, C., La Rosa, C. et al. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 1993, 67, 4742-4749
18. De Ronde, A., Stam, J.G., Boers, P. et al. Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 1994, 198, 257-264
19. Verschoor, EJ., Boven, L.A., Blaak, H., Van Vliet, A.L.W., Horzinek, M.C. and De Ronde, A. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol. 1995, 69, 4752-4757
20. Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 1993, 57, 183-289
21. Verschoor, E.J., Hulskotte, E.G.J., Ederveen, J., Koolen, M.J.M., Horzinek, M.C. and Rottier, P.J.M. Post-translational processing of the feline immunodeficiency virus envelope precursor protein. Virology 1993, 193, 433-438
22. Willemse, M.J., Chalmers, W.S.K., Cronenberg, A.M., Pfundt, R., Strijdveen, I.G.L. and Sondermeijer, P.J.A. The gene down-steam of the gC homologue in feline herpes virus type 1 is involved in the expression of virulence. J. Gen. Virol 1994, 75, 3107-3116
23. Sondermeijer, P.J.A., Claessens, J.A.J., Jenniskens, P.E. et al. Avian herpesvirus as a live viral vector for the expression of heterologous antigens. Vaccine 1993, 11, 349-358
24. Verschoor, E.J., Van Vliet, A.L.W., Egberink, H.F. et al. Vaccination against feline immunodeficiency virus using fixed infected cells. Vet. Immunol. Immunopathol. 1995, 46, 139-149
25. Verschoor, E.J., Van Vliet, A.L.W., Egberink, H.F., Hesselink, W., Horzinek, M.C. and De Ronde, A. Expression of feline immunodeficiency virus gag and env precursor proteins in Spodoptera frugiperda cells and their use in immunodiagnosis. J. Clin. Microbiol. 1993, 31, 2350-2355
26. Bomford, R., Stapleton, M., Winsor, S., McKnight, A. and Andronova, T. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. AIDS Res. Hum. Retrovir. 1992, 8, 1765-1771
27. Newman, M.J., Wu, J.-Y., Gardner, B.H. et al. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J. Immunol. 1992, 148, 2357-2362
28. Hem, S.L. and White, J.L. Characterization of aluminium hydroxide for use as an adjuvant in parenteral vaccines. J. Parent. Sci. Technol. 1984, 38, 2-10
29. Wu, J.-Y., Gardner, B.H., Murphy, C.I. et al. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 1992, 148, 1519-1525
30. 3 and saponin is related to the immunogenicity of the antigen. Int. Archs Allergy Appl. Immunol. 1984, 75, 280-281
31. Osterhaus, A., Weijer, K., Uytdehaag, F. et al. Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine. Vaccine 1989, 7, 137-141
32. Pyle, S.W., Morein, B., Bess, J.W. et al. Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine 1989, 7, 465-473
33. Powell, M.F., Cleland, J.L., Eastman, D.J. et al. Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons. AIDS Res. Hum. Retrovir. 1994, 10 Suppl. 2, S105-S108
34. Marciani, D.J., Kensil, C.R., Beltz, G.A., Hung, C., Cronier, J. and Aubert, A. Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats. Vaccine 1991, 9, 89-96
35. Wardley, R.C., Berlinski, P.J., Thomsen, D.R., Meyer, A.L. and Post, L.E. The use of feline herpesvirus and baculovirus as vaccine vectors for the gag and env genes of feline leukaemia virus. J. Gen. Virol. 1992, 73, 1811-1818
36. Hosie, M.J., Osborne, R., Reid, G., Neil, J.C. and Jarrett, O. Enhancement after feline immunodeficiency virus vaccination. Vet. Immunol. Immunopathol. 1992, 35, 191-197
37. Siebelink, K.H.J., Tijhaar, E., Huisman, R.C. et al. Enhancement of feline immunodeficiency virus infectivity after immunization with envelope glycoprotein subunit vaccines. J. Virol. 1995, 69, 3704-3711
38. Lombardi, S., Garzelli, C., Pistello, M. et al. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J. Virol. 1994, 68, 8374-8379